Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Interest & Investment Income (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Interest & Investment Income for 10 consecutive years, with $81606.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income rose 585.36% year-over-year to $81606.0, compared with a TTM value of $167103.0 through Dec 2025, up 91.29%, and an annual FY2025 reading of $167103.0, up 91.29% over the prior year.
  • Interest & Investment Income was $81606.0 for Q4 2025 at Abvc Biopharma, up from $47287.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $81606.0 in Q4 2025 and bottomed at -$29388.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $33547.8, with a median of $39595.0 recorded in 2022.
  • The sharpest move saw Interest & Investment Income plummeted 193.58% in 2021, then soared 585.36% in 2025.
  • Year by year, Interest & Investment Income stood at -$29388.0 in 2021, then surged by 305.74% to $60463.0 in 2022, then crashed by 38.01% to $37483.0 in 2023, then plummeted by 68.23% to $11907.0 in 2024, then skyrocketed by 585.36% to $81606.0 in 2025.
  • Business Quant data shows Interest & Investment Income for ABVC at $81606.0 in Q4 2025, $47287.0 in Q3 2025, and $19139.0 in Q2 2025.